36 research outputs found

    Identification of diagnostic serum protein profiles of glioblastoma patients

    Get PDF
    Diagnosis of a glioblastoma (GBM) is triggered by the onset of symptoms and is based on cerebral imaging and histological examination. Serum-based biomarkers may support detection of GBM. Here, we explored serum protein concentrations of GBM patients and used data mining to explore profiles of biomarkers and determine whether these are associated with the clinical status of the patients. Gene and protein expression data for astrocytoma and GBM were used to identify secreted proteins differently expressed in tumors and in normal brain tissues. Tumor expression and serum concentrations of 14 candidate proteins were analyzed for 23 GBM patients and nine healthy subjects. Data-mining methods involving all 14 proteins were used as an initial evaluation step to find clinically informative profiles. Data mining identified a serum protein profile formed by BMP2, HSP70, and CXCL10 that enabled correct assignment to the GBM group with specificity and sensitivity of 89 and 96%, respectively (pĀ <Ā 0.0001, Fischerā€™s exact test). Survival for more than 15Ā months after tumor resection was associated with a profile formed by TSP1, HSP70, and IGFBP3, enabling correct assignment in all cases (pĀ <Ā 0.0001, Fischerā€™s exact test). No correlation was found with tumor size or age of the patient. This study shows that robust serum profiles for GBM may be identified by data mining on the basis of a relatively small study cohort. Profiles of more than one biomarker enable more specific assignment to the GBM and survival group than those based on single proteins, confirming earlier attempts to correlate single markers with cancer. These conceptual findings will be a basis for validation in a larger sample size

    Plasma exchange in Immunoglobulin A nephropathy with thrombotic microangiopathy and acute cortical necrosis

    No full text
    A 25-year-old female presented with decreased urine output, deranged renal function, thrombocytopenia, and hemolytic anemia. Kidney biopsy was consistent with thrombotic microangiopathy with acute cortical necrosis and Immunoglobulin A nephropathy (IgAN). Hemolytic anemia, thrombocytopenia and urine output improved after five sessions of plasma exchange. Renal function showed a delayed recovery and serum creatinine normalized by 3 months. This is first case of successful use of plasma exchange in hemolytic uremic syndrome with cortical necrosis associated with IgAN

    Mass distribution in 36.2 MeV alpha induced fission of

    No full text
    Mass distribution of fission products has been determined in \upalpha +^{\mathrm {232}}\hbox {Th} reaction at Elab=36.2E_{\mathrm {lab}}=36.2 MeV using \upalpha particles from the cyclotron at the Variable Energy Cyclotron Centre (VECC), Kolkata. Yields of 64 fission products having half-lives in the range of about āˆ¼1\sim 1 min to several days have been measured using gamma ray spectrometry. The mass distribution shows a clear triple humped structure indicating the contribution from both asymmetric and symmetric modes of fission. The experimental mass distribution was well reproduced by the calculation from the GEF code, which takes into account the multi-chance fission
    corecore